Cloud Hosting

Fujifilm has a long and proven reputation as a trailblazer in medical imaging, and is committed to continuing to innovate and drive positive change in artificial intelligence, said Takuya Shimomura,Chief Technology Officer and Executive Director, FUJIFILM Medical Systems U.S.A., Inc. At RSNA 2019, we look forward to sharing the AI insights and advances weve made by working closely with clinical and research partners for several years. Ultimately, the long-term goal of our AI initiative is to help providers make better decisions that improve patient lives.

Underthe REiLI brand, Fujifilm is developing AI technologies that strongly support diagnostic imaging workflow, leveraging the combination of its deep learning innovations and distinct image processing heritage. Applications currently in development include, but are not limited to: Region Recognition, an AI technology that helps to accurately recognize and consistently extract organ regions, regardless of deviations in shape, presence or absence of disease, and imaging conditions; Computer Aided Detection, an AI technology to reduce the time of image interpretation and support radiologists clinical decision making; Workflow Support, using AI technology to realize optimal study prioritization, alert communications of AI findings, and report population automation.

Read More: Merkle Releases Its Q3 2019 Digital Marketing Report

Our latest Synapse 7x brings diagnostic radiology, mammography and cardiology together on the server-side, enabling immediate interaction with these modality imaging data sets through a single AI-enabled platform, saidBill Lacy, Vice President, Medical Informatics, FUJIFILM Medical Systems U.S.A., Inc. Were excited to debut this solution for our US customers at RSNA 2019, showing our commitment to progressing AI technology to empower physicians to make more efficient and impactful care decisions.

At booth #4111, attendees can visit Fujifilms AI Lab. The lab will feature dedicated workstations demonstrating REiLI use cases within Synapse PACS. Attendees can witness first-hand the speedand depth of the integrated workflows achieved by unifying Fujifilms REiLI technology with the companys server-side PACS system. Featured in the AI lab will be Fujifilm developed algorithms, to include CT lung nodule, intracerebral hemorrhage, cerebral infarction MR & CT, spine label and bone temporal subtraction to name a few. In addition to the Fujifilm AI development, the AI lab will showcase its strengths by supporting a multitude of integration points in support of partner vendor and provider developed algorithms. This will include Riverains lung nodule, MaxQs stroke, Lunits Chest & 2D Mammography, LPixels MR Aneurysm, Koios US breast, Aidocs pulmonary embolism and Gleamers bone fracture.

Read More: Education Index Launches The First University Application Prep Platform On Blockchain

Hear from practicing radiologists, and those that support them, on how Artificial Intelligence (AI) is currently impacting their workflows, and what considerations they would recommend for future deployments. Led by Fujifilms Enterprise Imaging experts, this interactive panel will provide unprecedented insights around the real-world use cases of one of todays most anticipated technologies.

Read More: Teradata Unifies IT, Marketing, and Customer Intelligence into Single CDP; Launches Vantage CX

Go here to see the original:

Fujifilm Showcases Artificial Intelligence Initiative And Advances AI - AiThority